Literature DB >> 1862015

Evaluation of an ibuprofen controlled-release tablet and placebo in postoperative oral surgery pain.

J A Forbes1, E M Moore, H W Allen, W T Beaver.   

Abstract

Seventy-four outpatients with postoperative pain after oral surgery were randomly assigned, on a double-blind basis, to receive a single oral dose of a controlled-release tablet (CRT) containing 600 mg ibuprofen, two 600-mg ibuprofen CRTs, or placebo. Using a self-rating record, subjects rated their pain and its relief hourly for 12 hours after medicating. Estimates of total and peak analgesia were derived from these subjective reports. The ibuprofen CRTs (600 and 1200 mg) had manifested an analgesic effect by hour 1 and their efficacy persisted for 12 hours. Comparable effect for the two ibuprofen CRT dosages could suggest a plateau in analgesia at the 600-mg level or a lack of upside assay sensitivity. Duration of effect was longer for the CRTs than we have previously observed with conventional ibuprofen tablets. Adverse effects were transitory and consistent with the known pharmacologic profile of the medication evaluated.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1862015

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  3 in total

1.  Summary of the scientific literature for pain and anxiety control in dentistry.

Authors:  L C Hassett
Journal:  Anesth Prog       Date:  1992

Review 2.  Single dose oral ibuprofen for acute postoperative pain in adults.

Authors:  Christopher Derry; Sheena Derry; R Andrew Moore; Henry J McQuay
Journal:  Cochrane Database Syst Rev       Date:  2009-07-08

3.  Analgesic Efficacy of a New Immediate-Release/Extended-Release Formulation of Ibuprofen: Results From Single- and Multiple-Dose Postsurgical Dental Pain Studies.

Authors:  Steven Christensen; Ed Paluch; Shyamalie Jayawardena; Stephen Daniels; Suzanne Meeves
Journal:  Clin Pharmacol Drug Dev       Date:  2016-09-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.